EFHD2 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	40 studies	45% ± 21%	Explore
macrophage	32 studies	37% ± 14%	Explore
classical monocyte	27 studies	50% ± 20%	Explore
conventional dendritic cell	27 studies	42% ± 18%	Explore
non-classical monocyte	23 studies	49% ± 22%	Explore
monocyte	21 studies	42% ± 17%	Explore
dendritic cell	19 studies	43% ± 23%	Explore
mature NK T cell	16 studies	38% ± 17%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	37% ± 19%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	56% ± 22%	Explore
myeloid cell	12 studies	47% ± 19%	Explore
gamma-delta T cell	12 studies	32% ± 11%	Explore
T cell	9 studies	21% ± 7%	Explore
mast cell	9 studies	32% ± 13%	Explore
CD8-positive, alpha-beta T cell	9 studies	36% ± 23%	Explore
CD8-positive, alpha-beta memory T cell	9 studies	27% ± 11%	Explore
ciliated cell	9 studies	33% ± 15%	Explore
neutrophil	9 studies	40% ± 4%	Explore
mucosal invariant T cell	9 studies	23% ± 7%	Explore
epithelial cell	9 studies	40% ± 14%	Explore
effector memory CD8-positive, alpha-beta T cell	8 studies	37% ± 20%	Explore
alveolar macrophage	7 studies	40% ± 11%	Explore
plasmacytoid dendritic cell	7 studies	27% ± 12%	Explore
leukocyte	7 studies	37% ± 18%	Explore
basal cell	7 studies	28% ± 20%	Explore
B cell	6 studies	21% ± 4%	Explore
secretory cell	6 studies	42% ± 19%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	32% ± 17%	Explore
mononuclear phagocyte	6 studies	43% ± 18%	Explore
enterocyte	6 studies	29% ± 9%	Explore
goblet cell	6 studies	26% ± 7%	Explore
glutamatergic neuron	6 studies	31% ± 13%	Explore
innate lymphoid cell	6 studies	33% ± 12%	Explore
endothelial cell	5 studies	23% ± 4%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	24% ± 3%	Explore
club cell	5 studies	22% ± 3%	Explore
respiratory goblet cell	5 studies	37% ± 5%	Explore
CD4-positive, alpha-beta T cell	5 studies	28% ± 20%	Explore
hematopoietic precursor cell	5 studies	32% ± 4%	Explore
intermediate monocyte	5 studies	52% ± 24%	Explore
regulatory T cell	5 studies	20% ± 6%	Explore
squamous epithelial cell	4 studies	45% ± 20%	Explore
inflammatory macrophage	4 studies	37% ± 12%	Explore
GABAergic neuron	4 studies	23% ± 4%	Explore
brush cell	4 studies	23% ± 5%	Explore
endothelial cell of vascular tree	4 studies	23% ± 4%	Explore
plasmablast	3 studies	30% ± 8%	Explore
platelet	3 studies	23% ± 4%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	3 studies	43% ± 19%	Explore
extravillous trophoblast	3 studies	38% ± 1%	Explore
microglial cell	3 studies	21% ± 2%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	17 studies	33% ± 14%	Explore
lung	11 studies	33% ± 18%	Explore
intestine	6 studies	20% ± 2%	Explore
brain	6 studies	24% ± 8%	Explore
liver	4 studies	22% ± 5%	Explore
placenta	3 studies	24% ± 5%	Explore
bone marrow	3 studies	27% ± 6%	Explore
uterus	3 studies	23% ± 9%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
pancreas	100%	4634.14	328 / 328	100%	263.78	178 / 178
stomach	100%	6565.27	359 / 359	100%	272.35	286 / 286
esophagus	100%	4439.77	1443 / 1445	100%	263.99	183 / 183
intestine	100%	7431.77	966 / 966	100%	276.54	525 / 527
uterus	100%	3649.04	170 / 170	100%	267.98	457 / 459
thymus	100%	5027.49	651 / 653	100%	303.24	604 / 605
bladder	100%	5434.33	21 / 21	99%	291.10	500 / 504
skin	100%	3839.70	1805 / 1809	99%	144.10	467 / 472
lung	100%	6828.10	576 / 578	98%	187.31	1135 / 1155
ovary	97%	2908.21	175 / 180	100%	129.58	430 / 430
prostate	100%	5261.71	245 / 245	95%	85.62	477 / 502
breast	100%	3217.84	459 / 459	93%	80.28	1036 / 1118
adrenal gland	100%	7937.95	258 / 258	90%	164.32	208 / 230
brain	89%	4359.65	2364 / 2642	97%	106.66	687 / 705
kidney	90%	2122.27	80 / 89	88%	76.68	794 / 901
liver	89%	1857.71	201 / 226	83%	63.28	335 / 406
lymph node	0%	0	0 / 0	100%	329.28	29 / 29
peripheral blood	100%	31373.57	929 / 929	0%	0	0 / 0
spleen	100%	15613.59	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	303.82	45 / 45
ureter	0%	0	0 / 0	100%	182.58	1 / 1
adipose	100%	4053.85	1199 / 1204	0%	0	0 / 0
blood vessel	96%	2425.78	1275 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	91%	82.38	73 / 80
heart	73%	1299.52	625 / 861	0%	0	0 / 0
muscle	3%	46.36	26 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0045121	Cellular component	membrane raft
GO_0005509	Molecular function	calcium ion binding
GO_0045296	Molecular function	cadherin binding

IV. Literature review

[source]

Gene name	EFHD2
Protein name	EF-hand domain-containing protein D2 (Swiprosin-1) EF-hand domain family member D2
Synonyms	SWS1
Description	FUNCTION: May regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis. Plays a role as negative regulator of the canonical NF-kappa-B-activating branch. Controls spontaneous apoptosis through the regulation of BCL2L1 abundance. .
Accessions	Q96C19 ENST00000445566.1 ENST00000375980.9 H0Y4Y4

EFHD2 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review